Spots Global Cancer Trial Database for Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
Official Title: A Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
Study ID: NCT05363488
Conditions
Interventions
Study Description
Brief Summary: This study will describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia (CML) used in a real world clinical practice setting.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
eatson West of Scotland Cancer Centre, Glasgow, , United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
